domingo, 20 de junio de 2021

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial - The Lancet Respiratory Medicine

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario